Hemostemix Inc (HEM) — Cash Flow-to-Debt Ratio
Hemostemix Inc (HEM) has a Cash Flow-to-Debt Ratio of -0.61x as of September 2025, meaning its operating cash flow of CA$-2.91 Million could theoretically repay -1% of its total liabilities (CA$4.80 Million) in one year. Explore Hemostemix Inc long-term investment intensity to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Hemostemix Inc Cash Flow-to-Debt Ratio (2013–2024)
Historical debt coverage capacity for Hemostemix Inc across 12 annual periods. Also explore how large is Hemostemix Inc's balance sheet for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Hemostemix Inc (2013–2024)
Year-by-year debt coverage analysis for Hemostemix Inc. For market capitalisation and broader financial context, see HEM stock market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (CAD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -0.23x | CA$-1.90 Million | CA$8.20 Million | ▼ -19.1% |
| 2023 | -0.19x | CA$-1.50 Million | CA$7.68 Million | ▲ +76.9% |
| 2022 | -0.84x | CA$-6.10 Million | CA$7.23 Million | ▼ -41.8% |
| 2021 | -0.59x | CA$-3.48 Million | CA$5.85 Million | ▲ +65.9% |
| 2020 | -1.75x | CA$-5.98 Million | CA$3.42 Million | ▼ -112.9% |
| 2019 | -0.82x | CA$-3.40 Million | CA$4.15 Million | ▲ +64.2% |
| 2018 | -2.29x | CA$-2.69 Million | CA$1.17 Million | ▲ +66.9% |
| 2017 | -6.91x | CA$-3.21 Million | CA$464.79K | ▼ -848.1% |
| 2016 | -0.73x | CA$-2.69 Million | CA$3.69 Million | ▲ +87.2% |
| 2015 | -5.69x | CA$-3.55 Million | CA$622.73K | ▼ -0.2% |
| 2014 | -5.68x | CA$-3.13 Million | CA$551.70K | ▼ -24.7% |
| 2013 | -4.56x | CA$-1.11 Million | CA$242.98K | — |